Skip to content

Making it to Market: Regulatory Insights for Paediatric Health Innovators

A concise training session exploring the regulatory essentials for paediatric MedTech, led by Carmen Martín and designed for early-stage innovators and healthcare professionals.
i4KIDS Training Capsule regulatory

In this training session, Carmen Martín, CEO and Founder of CMGMedDev, explores the key regulatory aspects for paediatric medical devices – from how to define your product’s intended purpose to how this affects classification and regulatory strategy.

Key topics:
✅ Defining the product’s intended purpose
✅ Impact on classification and regulatory strategy
✅ Expected processes, timelines, and investment
✅ Specific paediatric regulations: Orphan Medical Devices, PIPs, and more

Aimed at innovators, entrepreneurs, and regulatory professionals working in paediatric and maternal healthcare.

Session in Spanish.

Related News
Cuidate RNE

Featured

i4KIDS has completed its first season of collaboration with RNE's Cuídate programme, featuring nine episodes focused on paediatric and foetal health innovation. The series brought together healthcare professionals, researchers and innovators to discuss advances in areas such as rare diseases, paediatric haematology, prematurity, neurodevelopment, congenital heart disease and paediatric palliative care.
Perinatal i4kids

Featured

i4KIDS is reinforcing its commitment to innovation in paediatric, fetal and maternal health by collaborating in two strategic initiatives currently open for applications: CRAASH Barcelona 2026 and DKV Challenge 2026. Both programmes offer new opportunities for startups and innovative projects seeking to accelerate the development, validation and adoption of solutions with an impact on maternal and child health.
i4KIDS Training Capsule

Uncategorized

i4KIDS and Catalonia.Health brought together startup leaders, researchers and healthcare professionals to discuss funding, regulatory strategy and international growth. The session featured Gisela Lorente (Aptadel Therapeutics), Marc Martinell (Minoryx Therapeutics) and Stefanos Theoharis (OneChain Immunotherapeutics), highlighting Barcelona's growing role as a leading hub for paediatric health innovation.